| Betterchem |

|
|
|
| FDA approval activities
for this prescription drug:
Carboplatin Injection USP, 50, 150 and 450 mg, Tentatively Approved Faulding Pharmaceutical ANDA 76-473 4/16/03 Carboplatin Injection USP, 50, 150 or 450 mg, Tentatively Approved American Pharmaceutical Partners, ANDA 76-235 5/22/02 Carboplatin Injection USP, 10 mgmL, Tentatively Approved Gensia Sicor ANDA 76-227 8/12/02 Carboplatin Injection USP, 50, 150 or 450 mg, Tentatively Approved Pharmachemie B.V. ANDA 76-162 1/14/03 Carboplatin Injection USP, 10 mg/mL, Tentatively Approved Bedford ANDA 76-039 6/6/03 Carboplatin Injection USP, 50, 150 & 450 mg, Tentatively Approved Bedford ANDA 76-099 Paraplatin (Carboplatin Aqueous) Solution Injection, Bristol-Myers Squibb Co. NDA 20-452 7/14/03 7/28/03 Paraplatin (Carboplatin) Injection Bristol-Myers Squibb NDA 19880/S011 2/14/02 3/8/02 Paraplatin (Carboplatin) Injection Bristol-Myers Squibb NDA 19880/S009 |
© 2009 Betterchem.com
|